• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
RNLX

RNLX

Renalytix Plc

NASDAQHealthcareMedical - Healthcare Information ServicesUS

USD0.21

+0.01 (+5.66%)

Company Profile

CEO

James R. McCullough

IPO Date

2020-07-17

Sector

Healthcare

Industry

Medical - Healthcare Information Services

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.21

Prev. Close

$0.20

Day Low

$0.19

Day High

$0.23

52W Low

$0.18

52W High

$2.40

Market Cap

$0.02B

Volume

0.73M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

10

Avg Positive

14.0%

Avg Negative

13.0%

Avg Neutral

72.9%

News Feed

3 High-Growth Stocks Truly Headed for the Moon

The Motley Fool·7/16/2021·↑ positive

Renalytix AI plc (RNLX) CEO James McCullough on Q3 2021 Results - Earnings Call Transcript

Seeking Alpha·6/15/2021·↓ negative

Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2021

GlobeNewsWire·6/15/2021·↓ negative

Renalytix AI falls after R&D costs help push it into hefty loss

Proactive Investors·6/15/2021·↓ negative

Leadership Additions Announced to Support Expanding US Government and Healthcare Provider KidneyIntelX Deployment

GlobeNewsWire·6/7/2021·↑ positive

Atrium Health, Wake Forest Baptist Health, Wake Forest School of Medicine and Renalytix Partner to Advance Kidney Health

GlobeNewsWire·5/19/2021·↑ positive

KidneyIntelX Demonstrates Performance and Informs Treatment Decisions in Multinational CANagliflozin CardioVAScular Assessment Study (CANVAS)

GlobeNewsWire·4/20/2021·↓ negative

Clinical Utility Study Demonstrates Primary Care Physicians Highly Likely to Order KidneyIntelX to Inform Care Decisions

GlobeNewsWire·4/8/2021·↑ positive

Multi-Center Study Finds KidneyIntelX 72% More Effective Than Current Standard of Care In Identifying Early-Stage Patients at High Risk for Kidney Disease Progression and Failure

GlobeNewsWire·4/5/2021·↓ negative

Renalytix AI plc Issue of Shares Under the 2020 Employee Share Purchase Plan, PDMR Dealing and Total Voting Rights

GlobeNewsWire·3/4/2021·↑ positive